Article
Loss of Hdac3 in osteoprogenitors increases bone expression of osteoprotegerin, improving systemic insulin sensitivity.
Journal of cellular physiology - 1 Apr 2018
McGee-Lawrence Meghan E, Pierce Jessica L, Yu Kanglun, Culpepper Natasha R, Bradley Elizabeth W, Westendorf Jennifer J
Abstract excerpt
Type 2 diabetes is an emerging global health epidemic. Foundations for new therapies are arising from understanding interactions between body systems. Bone-derived factors that reduce RANKL (receptor activator of NF-kappa B ligand) signaling in the liver may prevent insulin resistance and the onset of type 2 diabetes. Here we demonstrate that deletion of the epigenetic regulator, Hdac3, in Osx1-expressing...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
